p21对细胞周期蛋白依赖性激酶（CDK）活性及增殖细胞核抗原（PCNA）依赖性DNA复制的抑制作用，会因与人类乳头瘤病毒16型（HPV-16）E7癌蛋白相互作用而被阻断。
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.
作者信息
Funk J O, Waga S, Harry J B, Espling E, Stillman B, Galloway D A
机构信息
Program in Cancer Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
出版信息
Genes Dev. 1997 Aug 15;11(16):2090-100. doi: 10.1101/gad.11.16.2090.
Abstract
p21 inhibits cyclin-dependent kinase (CDK) activity and proliferating cell nuclear antigen (PCNA)-dependent DNA replication by binding to CDK/cyclin complexes and to PCNA through distinct domains. The human papillomavirus (HPV)-16 E7 oncoprotein (16E7) abrogated a DNA damage-induced cell cycle arrest in vivo, despite high levels of p21. Using cell lysates and purified proteins we show that 16E7 prevented p21 both from inhibiting CDK2/cyclin E activity and PCNA-dependent DNA replication, whereas the nononcogenic HPV-6 E7 had reduced effects. Inactivation of both inhibitory functions of p21 was attained through binding between 16E7 and sequences in the carboxy-terminal end of p21 that overlap with the PCNA-binding site and the second p21 cyclin-binding motif. These data imply that the carboxyl terminus of p21 simultaneously modulates both CDK activity and PCNA-dependent DNA replication and that a single protein, 16E7, can override this modulation to disrupt normal cell cycle control.
摘要
p21通过不同结构域与细胞周期蛋白依赖性激酶（CDK）复合物及增殖细胞核抗原（PCNA）结合，从而抑制CDK活性和PCNA依赖性DNA复制。人乳头瘤病毒（HPV）-16 E7癌蛋白（16E7）在体内可消除DNA损伤诱导的细胞周期停滞，尽管p21水平很高。利用细胞裂解物和纯化蛋白，我们发现16E7既能阻止p21抑制CDK2/细胞周期蛋白E活性，又能阻止其抑制PCNA依赖性DNA复制，而非致癌性HPV-6 E7的作用则较弱。通过16E7与p21羧基末端与PCNA结合位点及第二个p21细胞周期蛋白结合基序重叠的序列之间的结合，实现了p21两种抑制功能的失活。这些数据表明，p21的羧基末端同时调节CDK活性和PCNA依赖性DNA复制，并且单一蛋白16E7可以克服这种调节，破坏正常的细胞周期控制。
相似文献
1
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.p21对细胞周期蛋白依赖性激酶（CDK）活性及增殖细胞核抗原（PCNA）依赖性DNA复制的抑制作用，会因与人类乳头瘤病毒16型（HPV-16）E7癌蛋白相互作用而被阻断。
Genes Dev. 1997 Aug 15;11(16):2090-100. doi: 10.1101/gad.11.16.2090.
2
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.人乳头瘤病毒E7癌蛋白可通过消除p21Cip1介导的对细胞周期蛋白依赖性激酶2（cdk2）的抑制作用，使人类角质形成细胞中的细胞分化与增殖脱钩。
Genes Dev. 1997 Aug 15;11(16):2101-11. doi: 10.1101/gad.11.16.2101.
3
Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.人乳头瘤病毒E7癌蛋白引发的DNA合成对p21介导的细胞周期蛋白E-细胞周期蛋白依赖性激酶2活性抑制具有抗性。
J Virol. 1997 Jul;71(7):5570-8. doi: 10.1128/JVI.71.7.5570-5578.1997.
4
5
Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.p21的细胞周期蛋白依赖性激酶-细胞周期蛋白（CDK-cyclin）和增殖细胞核抗原（PCNA）结合结构域对生长的抑制作用通过不同机制发生，并受泛素-蛋白酶体途径调控。
Oncogene. 1999 May 27;18(21):3290-302. doi: 10.1038/sj.onc.1202681.
6
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.p21Cip1中独立的细胞周期蛋白依赖性激酶（CDK）和增殖细胞核抗原（PCNA）结合域对细胞周期的抑制作用
Nature. 1995 May 11;375(6527):159-61. doi: 10.1038/375159a0.
7
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.p21的不同结构域参与对细胞周期蛋白依赖性激酶（Cdk激酶）和增殖细胞核抗原（PCNA）的抑制作用。
Nature. 1995 Mar 23;374(6520):386-8. doi: 10.1038/374386a0.
8
Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.p21的细胞周期蛋白依赖性激酶-细胞周期蛋白（CDK- cyclin）和增殖细胞核抗原（PCNA）结合域所介导的生长抑制通过不同机制发生，并受泛素-蛋白酶体途径调控。
Oncogene. 1999 Jul 29;18(30):4313-25. doi: 10.1038/sj.onc.1202686.
9
E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).E7 通过 p21（Cip1）的定位错误消除 raf 诱导的细胞停滞。
Mol Cell Biol. 2002 Oct;22(20):7041-52. doi: 10.1128/MCB.22.20.7041-7052.2002.
10
Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells.人乳头瘤病毒16型E7癌蛋白使视网膜母细胞瘤肿瘤抑制因子和p21均失活，这对于抑制人上皮细胞的细胞周期停滞是必要的。
J Virol. 2002 Oct;76(20):10559-68. doi: 10.1128/jvi.76.20.10559-10568.2002.
引用本文的文献
1
Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use.人乳头瘤病毒在癌症中的作用：致癌机制与临床应用
Signal Transduct Target Ther. 2025 Jan 24;10(1):44. doi: 10.1038/s41392-024-02083-w.
2
The Natural History of Cervical Cancer and the Case for MicroRNAs: Is Human Papillomavirus Infection the Whole Story?宫颈癌的自然史与微小RNA的情况：人乳头瘤病毒感染是全部原因吗？
Int J Mol Sci. 2024 Dec 3;25(23):12991. doi: 10.3390/ijms252312991.
3
Conofolidine: A Natural Plant Alkaloid That Causes Apoptosis and Senescence in Cancer Cells.苦参碱：一种导致癌细胞凋亡和衰老的天然植物生物碱。
Molecules. 2024 Jun 4;29(11):2654. doi: 10.3390/molecules29112654.
4
Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy.妇科癌症与微生物组动态：发病机制与治疗的新视角。
Int J Mol Sci. 2024 Feb 13;25(4):2237. doi: 10.3390/ijms25042237.
5
The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus.宫颈癌的特征：人乳头瘤病毒诱导的分子机制
Biology (Basel). 2024 Jan 27;13(2):77. doi: 10.3390/biology13020077.
6
The role of cell-matrix adhesion and cell migration in breast tumor growth and progression.细胞-基质黏附与细胞迁移在乳腺肿瘤生长和进展中的作用。
Front Cell Dev Biol. 2024 Feb 5;12:1339251. doi: 10.3389/fcell.2024.1339251. eCollection 2024.
7
Protein-DNA Interactions Regulate Human Papillomavirus DNA Replication, Transcription, and Oncogenesis.蛋白质-DNA 相互作用调控人乳头瘤病毒 DNA 复制、转录和致癌作用。
Int J Mol Sci. 2023 May 9;24(10):8493. doi: 10.3390/ijms24108493.
8
Human Papilloma Virus: An Unraveled Enigma of Universal Burden of Malignancies.人乳头瘤病毒：解开恶性肿瘤全球负担之谜
Pathogens. 2023 Apr 6;12(4):564. doi: 10.3390/pathogens12040564.
9
For Better or Worse: Modulation of the Host DNA Damage Response by Human Papillomavirus.好或坏：人乳头瘤病毒对宿主 DNA 损伤反应的调节。
Annu Rev Virol. 2023 Sep 29;10(1):325-345. doi: 10.1146/annurev-virology-111821-103452. Epub 2023 Apr 11.
10
Urocortin stimulates the ERK1/2 signaling pathway and the proliferation of HeLa cells via CRF receptor 1.尿皮质素通过 CRF 受体 1 刺激 ERK1/2 信号通路和 HeLa 细胞的增殖。
FEBS Open Bio. 2023 May;13(5):818-832. doi: 10.1002/2211-5463.13602. Epub 2023 Apr 2.
本文引用的文献
1
New functional activities for the p21 family of CDK inhibitors.细胞周期蛋白依赖性激酶抑制剂p21家族的新功能活性。
Genes Dev. 1997 Apr 1;11(7):847-62. doi: 10.1101/gad.11.7.847.
2
Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.对表达人乳头瘤病毒16型E7癌蛋白的细胞中p53介导的G1期生长停滞途径的分析。
J Virol. 1997 Apr;71(4):2905-12. doi: 10.1128/JVI.71.4.2905-2912.1997.
3
Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1.基于p21WAF1羧基末端结构域的小肽对细胞周期的阻滞及Cdk4活性的抑制
Curr Biol. 1997 Jan 1;7(1):71-80. doi: 10.1016/s0960-9822(06)00029-7.
4
Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.人乳头瘤病毒16型E7癌蛋白使细胞周期蛋白依赖性激酶抑制剂p27KIP1失活。
Oncogene. 1996 Dec 5;13(11):2323-30.
5
Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors.鉴定存在于底物和p21样细胞周期蛋白依赖性激酶抑制剂中的细胞周期蛋白-cdk2识别基序。
Mol Cell Biol. 1996 Dec;16(12):6623-33. doi: 10.1128/MCB.16.12.6623.
6
Papillomavirus infections--a major cause of human cancers.乳头瘤病毒感染——人类癌症的主要成因。
Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78. doi: 10.1016/0304-419x(96)00020-0.
7
Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.游离态及与Cdk2结合态的p21Waf1/Cip1/Sdi1的结构研究：构象无序介导结合多样性
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11504-9. doi: 10.1073/pnas.93.21.11504.
8
Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA.与人类增殖细胞核抗原复合的p21（WAF1/CIP1）C端区域的结构
Cell. 1996 Oct 18;87(2):297-306. doi: 10.1016/s0092-8674(00)81347-1.
9
10
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation.人乳头瘤病毒16型E7对生长停滞信号的消除是由转化所需的序列介导的。
J Virol. 1996 Oct;70(10):6862-9. doi: 10.1128/JVI.70.10.6862-6869.1996.
Zotero 插件